Generate text that refutes this claim: Patenting drives up the cost of therapies and renders them unaffordable to the poor  The government and its laws should take care of all their people. Because the state is a construct built by all the people, who all pay taxes to support it, laws should also be based to benefit the greatest amount of people possible.In the case of the Myriad company, which holds, together with the University of Utah Research Foundation, rights over tests for ovarian cancer, it prevented cheaper tests being offered to the public. As a result, Myriad is the only company that can market a test for the mutations, and it charges as much as $3,000 . That is a price that for many is inaccessible. Patients’ state: “There is no other, cheaper test that you could go get in another laboratory, because they have the exclusive patent,” she explained, adding that Myriad also controls the efficacy of the test—second opinions are only available for certain surgeries 1.Because patenting harms the accessibility of diagnostics and testing, it should not be allowed.  1. Pratt P.A., Court Rules That DNA Is Information, Not Intellectual Property, published March 30th 2010,  , accessed 07/20/2011
aw society family house would allow patenting genes
Firstly, it is not self-evident, that people have a right to use and possess something, such as medicine that they did not create.So why should people have the right to use a product that someone else discovered through the power of their own cognitive abilities. Actually demands to not patent and just research for the greater good are contradictory to the government taking care of all their people. The best way for the government to encourage medical research that provides these benefits is through patents. Patenting of genes is therefore a right that is based on the right to ownership of your own thoughts and should therefore be granted to the companies / individuals. There is no consistent legal basis for deciding that genes are not patent-eligible without deciding that many other ‘natural products’ are also ineligible.